Published in J Immunol Methods on June 24, 1991
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. Proc Natl Acad Sci U S A (1992) 1.37
Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine (2012) 1.21
Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice. Infect Immun (1996) 1.08
Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages. Infect Immun (1992) 1.01
Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen. Infect Immun (1998) 0.98
Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections. Infect Immun (2004) 0.94
Liposomes as vaccine delivery systems: a review of the recent advances. Ther Adv Vaccines (2014) 0.93
A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle. Hum Vaccin Immunother (2013) 0.91
Enhancing nicotine vaccine immunogenicity with liposomes. Bioorg Med Chem Lett (2012) 0.91
Optimization of a Method to Prepare Liposomes Containing HER2/Neu- Derived Peptide as a Vaccine Delivery System for Breast Cancer. Iran J Pharm Res (2014) 0.90
Negatively charged liposomes show potent adjuvant activity when simply admixed with protein antigens. Mol Pharm (2011) 0.84
The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes. Immunology (1993) 0.84
Induction of primary antigen-specific immune reponses in SCID-hu-PBL by coupled T-B epitopes. Immunology (1995) 0.84
Particle-mediated delivery of cytokines for immunotherapy. Immunotherapy (2012) 0.82
Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett (2013) 0.81
Adjuvant effect of cationic liposomes for subunit influenza vaccine: influence of antigen loading method, cholesterol and immune modulators. Pharmaceutics (2013) 0.80
Tresyl-based conjugation of protein antigen to lipid nanoparticles increases antigen immunogenicity. Int J Pharm (2010) 0.78
Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis. Br J Pharmacol (1999) 0.78
Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice. PLoS One (2015) 0.78
Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research. Biomed Res Int (2013) 0.78
New age adjuvants and delivery systems for subunit vaccines. Indian J Clin Biochem (2000) 0.77
Modification of alpha 2-macroglobulin into a macrophage-activating factor through the action of liposome-stimulated B-cell membranous glycosidases. Immunology (1995) 0.77
Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory. Immunology (1993) 0.77
Preparation and characterization of different liposomal formulations containing P5 HER2/neu-derived peptide and evaluation of their immunological responses and antitumor effects. Iran J Basic Med Sci (2015) 0.75
Developing peptide based immunogen against human malaria delivered in liposomes containing non-toxic adjuvants. Indian J Clin Biochem (1997) 0.75
Mouse Model of Cat Allergic Rhinitis and Intranasal Liposome-Adjuvanted Refined Fel d 1 Vaccine. PLoS One (2016) 0.75
Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. Immunol Lett (1990) 0.97
Naturally occurring autoantibodies to cholesterol in humans. Biochem Soc Trans (1989) 0.84
Immunologic aspects of liposomes: presentation and processing of liposomal protein and phospholipid antigens. Biochim Biophys Acta (1992) 0.83
Novel adjuvant strategies for experimental malaria and AIDS vaccines. Ann N Y Acad Sci (1993) 0.82
Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atherosclerosis and autoimmunity. Crit Rev Immunol (1991) 0.81
Liposomes containing lipid A as a potent non-toxic adjuvant. Res Immunol (1992) 0.77
Antibodies to liposomes, phospholipids, and cholesterol: implications for autoimmunity, atherosclerosis, and aging. Prog Clin Biol Res (1990) 0.75
Summary: Adjuvants/Clinical Trials Working Group. AIDS Res Hum Retroviruses (1992) 0.75